Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Gaush Meditech Ltd. ( (HK:2407) ) has provided an update.
Gaush Meditech Ltd announced that its subsidiary, Gaush Teleon Ltd, has been awarded the ISO 13485:2016/EN ISO 13485:2016 Quality Management System Certification for Medical Devices by DEKRA. This certification highlights the company’s commitment to quality management, risk control, and regulatory compliance, and positions it for further international market expansion.
The most recent analyst rating on (HK:2407) stock is a Buy with a HK$10.50 price target. To see the full list of analyst forecasts on Gaush Meditech Ltd. stock, see the HK:2407 Stock Forecast page.
More about Gaush Meditech Ltd.
Gaush Meditech Ltd, incorporated in the Cayman Islands, operates in the medical device industry, focusing on the design, development, production, and sale of intraocular lenses for cataract and presbyopia treatment, along with supporting implant systems.
Average Trading Volume: 163,458
Technical Sentiment Signal: Hold
Current Market Cap: HK$1.31B
Find detailed analytics on 2407 stock on TipRanks’ Stock Analysis page.